Effects of L-carnitine and its acetyl and propionyl esters on ATP and PCr levels of isolated rat hearts perfused without fatty acids and investigated by means of 31P-NMR spectroscopy

Molecular and Cellular Biochemistry

Volumn 200, Issue 1-2, 1999, Pages 93-102

  Löster, Heinz ^a   Keller, Thomas ^b   Grommisch, Jens ^b   Gründer, Wilfried ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b NONE

Author keywords

31P magnetic resonance spectroscopy; Carnitine esters; Energy rich phosphates; L carnitine; Myocardial damage; Reperfusion injury

Indexed keywords

ACETYLCARNITINE; ADENOSINE TRIPHOSPHATE; CARNITINE; CREATINE PHOSPHATE; FATTY ACID; PHOSPHATE; PROPIONYLCARNITINE;

ANIMAL TISSUE; ARTICLE; CELL PH; CONTROLLED STUDY; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE REPERFUSION; HEART PROTECTION; HIGH ENERGY PHOSPHATE; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; RAT; REPERFUSION INJURY;

ACETYLCARNITINE; ADENOSINE TRIPHOSPHATE; ANIMALS; CARNITINE; ENERGY METABOLISM; FEMALE; HEART; MAGNETIC RESONANCE SPECTROSCOPY; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PERFUSION; PHOSPHATES; PHOSPHOCREATINE; RATS; RATS, WISTAR;

EID: 0344200102     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006966817286     Document Type: Article

References (94)

1. Bremer J: Carnitine in intermediary metabolism. The metabolism of fatty acid esters of carnitine by mitochondria. J Biol Chem 237: 3628-3632, 1962
2. Fritz IB: Carnitine and its role in fatty acid metabolism. Adv Lipid Res 1: 285-334, 1963
3. Pande SV, Parvin R: Carnitine-acylcarnitine translocase-mediated transport of fatty acids into mitochondria: its involvement in the control of fatty acid oxidation in liver. In: R.A. Frenkel, J.D. McGarry (eds.) Carnitine Biosynthesis, Metabolism, and Functions. Academic Press, New York, pp. 143-157, 1980
4. Ramsay RR, Tubbs PK : The mechanism of fatty acid uptake by heart mitochondria: an acylcarnitine-carnitine exchange. FEBS Lett 54: 21-25, 1975
5. Wang HY, Baxter CF Jr, Schulz H: Regulation of fatty acid β-oxidation in rat heart mitochondria. Arch Biochem Biophys 289: 274-280, 1991
6. Bieber LL: Carnitine. Ann Rev Biochem 57: 261-283, 1988
7. Bremer J: Carnitine: metabolism and functions. Physiol Rev 63: 1420-1480, 1983
8. Siliprandi N, Sartorelli L, Ciman M, Di Lisa F: Carnitine: metabolism and clinical chemistry. Clin Chim Acta 183: 3-11, 1989
9. Dhalla NS, Elimban V, Rupp H: Paradoxical role of lipid metabolism in heart function and dysfunction. Mol Cell Biochem 116: 3-9, 1992
10. Fritz IB, Kaplan E, Yue KTN: Specificity of carnitine action on fatty acid oxidation by heart muscle. Am J Physiol 202: 117-121, 1962
11. Opie LH: Role of carnitine in fatty acid metabolism of normal and ischemic myocardium. Am Heart J 97: 375-388, 1979
12. Balaban RS, Kantor HL, Feretti JA: In vivo flux between phosphocreatine and adenosine triphosphate determined by two-dimensional phosphorus NMR. J Biol Chem 258: 12787-12789, 1983
13. Bittl JA, Ingwall JS: Reaction rates of creatine kinase and ATP synthesis in the isolated heart. A 31P NMR magnetization transfer study. J Biol Chem 260: 3512-3517, 1985
14. Zweier JL, Jacobus E: Substrate-induced alteration of high energy phosphate metabolism and contractile function in the perfused heart. J Biol Chem 262: 8015-8021, 1987
15. 31P NMR study. Proc Natl Acad Sci USA 78: 6714-6718, 1981
16. Chance B, Leigh JS, Clark BJ, Maris J, Kent J, Nicka S, Smith D: Control of oxidative metabolism and oxygen delivery in human skeletal muscle: A steady state analysis of the work/energy cost transfer function. Proc Natl Acad Sci USA 82: 8384-8388, 1985
17. 1H-magnetic resonance spectroscopy in the rabbit heart. Jpn Circ J 58: 707-712, 1994
18. Ferrari R, Ceconi C, Curello S, Pasini E, Visioli O: Protective effect of propionyl-L-carnitine against ischaemia and reperfusion-damage. Mol Cell Biochem 88: 161-168, 1989
19. Siliprandi, N, Di Lisa F, Menabo R.: Propionyl-L-carnitine: biochemical significance and possible role in cardiac metabolism. Cardiovasc Drugs Ther 5 (Suppl 1): 11-15, 1991
20. Döring HJ: The isolated perfused heart according to Langendorff technique - function - application. Physiol Bohemoslovaca 39: 481-504, 1990
21. Broderick TL, Quinney HA, Lopaschuk GD: Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart. J Biol Chem 267: 3758-3763, 1992
22. Johnston DJ, Liu P, Okada RD: Assessment of myocardial ischemia and infarction by magnetic resonance imaging. In: M. Osbakken, J. Haselgrove (eds.). NMR techniques in the study of cardiovascular structure and function. Futura Publ. Comp., Mount Kisco, New York, pp. 95-122, 1988
23. Balaban RS: NMR Spectroscopy of the heart, Part I. Concepts in Magnetic Resonance 1: 15-26, 1989
24. Elgavish GA: MR Spectroscopy of the intact heart. In: L.J. Berliner, J. Reuben (eds). Biological Magnetic Resonance, Vol 7, Plenum Publishing Corporation, New York, London, pp. 1-80, 1987
25. 31P NMR in living tissue: the road from a promising to an important tool in biology. In: R.G. Shulman (ed.). Biological applications of magnetic resonance. Academic Press, New York, pp. 463-535, 1979
26. Ingwall JS: Phosphorus nuclear magnetic resonance spectroscopy of cardiac and skeletal muscles. Am J Physiol 343: H729-H744, 1982
27. Radda GK: Some new insights into biology and medicine trough NMR spectroscopy. Phil Trans R Soc Lond A 333: 515-524, 1990
28. Iles RA, Stevens AN, Griffiths JR: NMR studies of metabolites in living tissues. Progr NMR Spectrosc 15: 49-200, 1982
29. 31P NMR magnetization transfer studies of the intact heart. In: R.K. Gupta (ed.). NMR spectroscopy of cells and organisms. Vol I., CRC Press, Boca Raton, pp. 51-68, 1987
30. Bittl JA, Ingwall JS: Intracellular high-energy phosphate transfer in normal and hypertrophied myocardium. Circulation 75: (Suppl I) 96-101, 1987
31. Cohen SM, Werrmann JG, King BW: Simultaneous 31P nuclear magnetic resonance spectroscopy and mechanical function in working heart models affected by drugs. Drug Dev Res 18: 305-325, 1989
32. Jacobsen L, Cohen JS: Intracellular pH measurements by NMR methods. In: J.S. Cohen (ed.). Noninvasive Probes of Tissue Metabolism. J Wiley, New York, pp. 5-24, 1982
33. 31P chemical shifts. Biochemistry 20: 5389-5394, 1981
34. Opie LH: Effect of fatty acids on contractility and rhythm of the heart. Nature 227: 1055-1056, 1970
35. Neely JR, Morgan HE: Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Ann Rev Physiol 36: 413-459, 1974
36. Lopaschuk GD, Broderick TL, Quinney AH, Saddik M: Both carnitine and carnitine palmitoyltransferase 1 inhibitors stimulate glucose oxidation in isolated hearts perfused with high concentrations of fatty acids. In: A.L. Carter (ed.). Current Concepts in Carnitine Research, CRC Press, Boca Raton, pp. 231-243, 1992
37. Lopaschuk GD, Saddik M: The relative contribution of glucose and fatty acids to ATP production in hearts reperfused following ischemia. Mol Cell Biochem 116: 111-116, 1992
38. Liedtke AJ: Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc Dis 23: 321-336, 1981
39. Hearse DJ: Cellular damage during myocardial ischemia: metabolic changes leading to enzyme leakage. In: D.J. Hearse, J. De Leiris, D. Loisance (eds.). Enzymes in Cardiology: Diagnosis and Research, J Wiley, Chichester, pp. 1-19, 1979
40. Hearse DJ, Humphrey SM, Bullock GR: Reoxygenation, reperfusion and the calcium paradox: studies of cellular damage and enzyme release. In: D.J. Hearse, J. De Leiris, D. Loisance (eds.). Enzymes in Cardiology: Diagnosis and Research, J Wiley, Chichester, pp. 417-444, 1979
41. Löster H, Punzel M: Effects of L-carnitine on mechanical recovery of isolated rat hearts in relation to the perfusion with glucose and palmitate. Mol Cell Biochem 185: 65-75, 1998
42. Bartels GL, Remme WJ, Pillay M, Schönfeld DHW, Cox PH, Kruijssen DACM, Knufman NMJ: Acute improvement of cardiac function with intravenous L-propionylcarnitine in humans. J Cardiovasc Pharmacol 20: 157-164, 1992
43. Chiddo A, Gaglione A, Musci S, Troito G, Grimaldi N, Locuratolo N, Rizzon P: Hemodynamic study of intravenous propionyl-L-carnitine in patients with ischemic heart disease and normal left ventricular function. Cardiovasc Drugs Ther 5 (Suppl 1): 107-111, 1991
44. Corsi C, Pollastri M, Marrapodi E, Leanza D, Giordano S, D'Iddio S: L-propionylcarnitine effect on postexercise and postischemic hyperemia in patients affected by peripheral vascular disease. Angiology 46: 705-713, 1995
45. Ferrari R, Di Lisa F, De Jong JW, Ceconi C, Pasini E, Barbato R, Menabo R, Barbieri M, Cerbai E, Mugielli A: Prolonged propionyl-L-carnitine pre-treatment of rabbit: biochemical, hemodynamic and electrophysiological effects on myocardium. J Mol Cell Cardiol 24: 219-232, 1992
46. Liedtke AJ, De Maison L, Nellis SH: Effects of L-propionylcarnitine on mechanical recovery during reflow in intact hearts. Am J Physiol 255: H169-176, 1988
47. Regitz V, Paulson DJ, Noonan J, Fleck E, Shug AL: Protection of the ischemic myocardium by propionylcarnitine taurine amide. Comparison with other carnitine derivatives. Z Kardiol 76 (Suppl 5): 53-58, 1987
48. Sassen LMA, Bezstarosti K, Koning MMG, Van der Giessen WJ, Lamers JMJ, Verdouw PD: Effects of administration of L-propionylcarnitine during ischemia on the recovery of myocardial function in the anesthetised pig. Cardioscience 1: 155-161, 1990
49. Rizzon P, Biasco G, DiBiase M, Boscia F, Rizzo U, Minafra F, Bortone A, Siliprandi N, Procopio A, Bagiella E, Corsi M: High doses of L-carnitine in acute myocardial infarction: metabolic and antiarrhythmic effects. Eur Heart J 10: 502-508, 1989
50. Ferrari R, De Giuli F: The propionyl-L-carnitine hypothesis: an alternative approach to treating heart failure. J Card Fail 3: 217-224, 1997
51. Bartels GL, Remme WJ, Holwerda KJ, Kruijssen DACM: Anti-ischemic efficacy of L-propionylcarnitine - a promising novel metabolic approach to ischemia? Eur Heart J 17: 414-420, 1996
52. Paulson DJ, Schmidt MJ, Romens J, Shug AL: Metabolic and physiological differences between zero-flow and low-flow myocardial ischemia: effects of 1-acetylcarnitine. Bas Res Cardiol 79: 551-561, 1984
53. Lopaschuk GD: Carnitine and myocardial glucose metabolism. In: C. De Simone, G. Famularo (eds.). Carnitine today, Springer-Verlag, Heidelberg, pp 71-93, 1997
54. Schönekess BO, Lopaschuk GD: The effects of carnitine on myocardial carbohydrate metabolism. In: J.W. De Jong and R. Ferrari (eds). The carnitine system: A new therapeutical approach to cardiovascular diseases, Kluver Academic Publishers, Dordrecht, pp. 39-52, 1995
55. Lopaschuk GD, Wall SR, Olley PM, Davies NJ: Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine. Circ Res 63: 1036-1043, 1988
56. 31P NMR at high magnetic fields. Biochim Biophys Res Comm 134: 1379-1386, 1986
57. Jeffrey FM, Storey CJ, Nunnally RL, Malloy CR: Effect of ischemia on NMR detection of phosphorylated metabolites in the intact rat heart. Biochemistry 28: 5323-5326, 1989
58. Pieper GM Murray WJ: In vivo and in vitro intervention with L-carnitine prevents abnormal energy metabolism in isolated diabetic rat heart: chemical and phosphorus-31 NMR evidence. Biochem Med Metab Biol 38: 111-120, 1987
59. Pieper GM, Salhany JM, Murray WJ, Wu ST, Eliot RS: Lipid-mediated impairment of normal energy metabolism in the isolated perfused diabetic rat heart studied by phosphorus-31 NMR and chemical extraction. Biochim Biophys Acta 803: 229-240, 1984
60. Pieper GM, Murray WJ, Salhany JM, Wu ST, Eliot RS: Salient effects of L-carnitine on adenine-nucleotide loss and coenzyme A acylation in the diabetic heart perfused with excess palmitic acid: A phosphorus-31 NMR and chemical extract study. Biochim Biophys Acta 803: 241-249, 1984
61. 31P nuclear-magnetic-resonance study. Biochem J 210: 477-481, 1983
62. Broderick TL, Haloftis G, Paulson DJ: L-propionylcarnitine enhancement of substrate oxidation and mitochondrial respiration in the diabetic rat heart. J Mol Cell Cardiol 28: 331-340, 1996
63. 32P-labelled ATP by isolated rabbit heart mitochondria. Biochim Biophys Res Commun 76: 882-887, 1977
64. Shug AL, Shrago E, Bittar N, Folts JD, Koke JR: Acyl-CoA inhibition of adenine nucleotide translocation in the ischemic myocardium. Am J Physiol 228: 689-692, 1975
65. Hansfort RG, Cohen L: Relative importance of pyruvate dehydrogenase interconversion and feed-back inhibition in the effect of fatty acids on pyruvate oxidation by rat heart mitochondria. J Biol Chem 253: 4310-4318, 1978
66. Kerbey AL, Randle PJ, Cooper RH, Whitehouse S, Pask HT, Denton RM: Regulation of pyruvate dehydrogenase in rat heart. Mechanism of regulation of proportions of dephosphorylated and phosphorylated enzyme by oxidation of fatty acids and ketone bodies and of effects of diabetes: role of coenzyme A, acetyl-coenzyme A and reduced and oxidized nicotinamide-adenine dinucleotide. Biochem J 154: 327-348, 1976
67. Patel MS, Roche TE: Molecular biology and biochemistry of pyruvate dehydrogenase complexes. FASEB J 4: 3224-3233, 1990
68. Shug AL, Thomsen JH, Folts JD, Bittar N, Klein MI, Koke JR, Huth PJ: Changes in tissue levels of carnitine and other metabolites during myocardial ischemia and anoxia. Arch Biochem Biophys 187: 25-33, 1978
69. Corr PB, Creer MH, Yamada KA, Saffitz JE, Sobel BE: Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest 83: 927-936, 1989
70. Feuvray D, Idell-Wenger JA, Neely JR: Effects of ischemia on rat myocardial function and metabolism in diabetes. Circ Res 44: 322-329, 1979
71. Madden MC, Wolkowicz PE, Pohost GM, Mc Millin JB, Pike MM: Acylcarnitine accumulation does not correlate with reperfusion recovery in palmitate-perfused rat hearts. Am J Physiol 268: H2505-H2512, 1995
72. Van der Vusse GJ, Glatz JFC, Stam HCG, Reneman RS: Fatty acid homeostasis in the normoxic and ischemic heart. Phys Rev 72: 881-940, 1992
73. Ramsay RR, Arduini A: The carnitine acyltransferases and their role in modulating acyl-CoA pools. Arch Biochem Biophys 302: 307-314, 1993
74. Chalmers RA, Roe CR, Tracey BM, Stacey RE, Hoppel CL, Millington DS: Secondary carnitine insufficiency in disorders of organic acid metabolism: modulation of acyl-CoA/CoA ratios by L-carnitine in vivo. Biochem Soc Trans 11: 724-725, 1983
75. Chua BH, Shrago E: Reversible inhibition of adenine nucleotide translocation by long chain acyl-CoA esters in bovine heart mitochondria and inverted submitochondrial particles. J Biol Chem 252: 6711-6714, 1977
76. Shug AL, Subramanian R: Modulation of adenine nucleotide translocase activity during myocardial ischemia. Z Kardiol 76 (Suppl 5): 26-33, 1987
77. Idell-Wenger JA, Grotyohann LW, Neely JR: Coenzyme A and carnitine distribution in normal and ischemic hearts. J Biol Chem 253: 4310-4318, 1978
78. Snoswell AM, Koundakjian PP: Relationship between carnitine and coenzyme A esters in tissues of normal and alloxan-diabetic sheep. Biochem J 127: 133-141, 1972
79. Suzuki Y, Kamikawa T, Kobayashi A, Yamazaki N: Effects of L-carnitine on tissue levels of free fatty acids, acyl-CoA, and acylcarnitine in ischemic heart. In: E. Chazov, V. Saks, G. Rona (eds.). Adv Myocardiol, Vol 4, Plenum Publ Corp, New York, pp. 549-557, 1983
80. El Alaoui-Talibi, Guendouz A, Moravec M, Moravec J: Control of oxidative metabolism in volume-overloaded hearts: effect of propionyl-L-carnitine. Am J Physiol 272: H1615-H1624, 1997
81. Cevese A, Schena F, Cerutti G: Short-term hemodynamic effects of intravenous propionyl-1-carnitine in anesthetized dogs. Cardiovasc Drugs Ther 5 (Suppl 1): 45-56, 1991
82. Broderick TL, Di Domenico D, Shug AL, Paulson DJ: L-propionyl-carnitine effects on cardiac carnitine content and function in secondary carnitine deficiency. Can J Physiol Pharmacol 73: 509-514, 1995
83. Barbieri M, Carbonin PU, Cerbai E, Gambassi G, Lo Giudice P, Masini I, Mugelli A, Pahor M: Lack of correlation between the antiarrhythmic effect of L-propionylcarnitine on reoxygenation-induced arrhythmias and its electrophysiological properties. Br J Pharmacol 102: 73-78, 1991
84. Ferrari R, Pasini E, Condorelli E, Boraso A, Lisciani R, Marzo A, Visioli O: Effect of propionyl-L-carnitine on mechanical function of isolated rabbit heart. Cardiovasc Drugs Ther 5 (Suppl 1): 17-23, 1991
85. Pasini E, Comini L, Ferrari R, De Giuli F, Menotti A, Dhalla NS: Effect of propionyl-L-carnitine on experimentally induced cardiomyopathy in rats. Am J Cardiovasc Pathol 4: 216-222, 1992
86. Paulson DJ, Traxler JS, Schmidt MJ, Noonan J, Shug AL: Protection of the ischaemic myocardium by L-propionylcarnitine: Effects of the recovery of cardiac output after ischaemia and reperfusion, carnitine transport, and fatty acid oxidation. Cardiovasc Res 20: 536-541, 1986
87. Russell RR, Mommessin JI, Taegtmeyer H: Propionyl-L-carnitine-mediated improvement in contractile function of rat hearts oxidizing acetoacetate. Am J Physiol 268: H441-H447, 1995
88. Siliprandi N, Di Lisa F, Pivetta A, Miotto G, Siliprandi D: Transport and function of L-carnitine and L-propionylcarnitine: relevance to some cardiomyopathies and cardiac ischemia. Z Kardiol 76 (Suppl 5): 34-40, 1987
89. Tassani V, Cattapan F, Magnanimi L, Peschechera A: Anaplerotic effect of propionyl carnitine in rat heart mitochondria. Biochem Biophys Res Commun 199: 949-953, 1994
90. Sundqvist KE, Vuorinen KH, Peuhkurinen KJ, Hassinen IE: Metabolic effects of propionate, hexanoate und propionylcarnitine in normoxia, ischemia and reperfusion: Does an anaplerotic substrate protect the ischaemic myocardium? Eur Heart J 15: 561-570, 1994
91. Kleber HP: Bacterial carnitine metabolism. FEMS Microbiol Lett 147: 1-9, 1997
92. Seim H, Löster H, Claus R, Kleber H-P, Strack E: Splitting of the C-N bond in carnitine by an enzyme (trimethylamine forming) from membrane of Acinetobacter calcoaceticus. FEMS Microbiol Lett 15: 165-167, 1982
93. Opie L: ATP synthesis and breakdown. In: L. Opie (ed.), The Heart: Physiology, Metabolism, Pharmacology and Therapy, Grune & Stratton Inc., London, pp. 136-153, 1986
94. Hata K, Takasago T, Saeki A, Nishioka T, Goto Y: Stunned myocardium after rapid correction of acidosis. Circ Res 74: 794-805, 1994